Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05304208
What this trial is testing

DENdritic Cell Therapy Combined With SURgEry in Mesothelioma

Who this might be right for
Mesotheliomas Pleural
Erasmus Medical Center 16
Not applicableNot Yet RecruitingNCT06994078
What this trial is testing

Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors

Who this might be right for
Urothelial CarcinomaBreast CancerLung Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56
Not applicableLooking for participantsNCT06910449
What this trial is testing

Hemithoracic Arc Radiotherapy Post Pleural Decortication

Who this might be right for
Malignant Pleural Mesothelioma
Cairo University 45
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Sinonasal Neuroendocrine CarcinomaNasopharyngeal CarcinomaEsthesioneuroblastoma+7 more
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT02435121
What this trial is testing

A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification

Who this might be right for
Neoplasm Malignant
Sanofi 1
Testing effectiveness (Phase 2)Ended earlyNCT03393858
What this trial is testing

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Who this might be right for
CancerMesothelioma, Malignant
Capital Medical University 10
Early research (Phase 1)Study completedNCT03054298
What this trial is testing

CAR T Cells in Mesothelin Expressing Cancers

Who this might be right for
Lung AdenocarcinomaOvarian CancerPeritoneal Carcinoma+3 more
University of Pennsylvania 65
Testing effectiveness (Phase 2)Ended earlyNCT05388435
What this trial is testing

Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Who this might be right for
Advanced Solid Tumor
SK Life Science, Inc. 15
Early research (Phase 1)Study completedNCT01997190
What this trial is testing

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Who this might be right for
Malignant Pleural EffusionLung CancerMesothelioma+2 more
Candel Therapeutics, Inc. 19
Not applicableStudy completedNCT05906823
What this trial is testing

Analysis of Metabonomics for Pleural Effusion

Who this might be right for
Pleural Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 300
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Testing effectiveness (Phase 2)Study completedNCT04021043
What this trial is testing

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Carcinoma in the LiverMetastatic Carcinoma in the Lung+2 more
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT01590160
What this trial is testing

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Lung Cancer - Malignant Pleural Mesothelioma
University College, London 27
Testing effectiveness (Phase 2)UnknownNCT03715985
What this trial is testing

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Who this might be right for
Malignant Melanoma, MetastaticNon Small Cell Lung Cancer MetastaticBladder Urothelial Carcinoma, Metastatic
Herlev Hospital 12
Not applicableStudy completedNCT03523689
What this trial is testing

Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy

Who this might be right for
Malignant Neoplasms of Respiratory and Intrathoracic OrgansLung Neoplasm
M.D. Anderson Cancer Center 57
Early research (Phase 1)UnknownNCT06256055
What this trial is testing

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Malignant MesotheliomaColorectal CancerBile Duct Cancer+4 more
UTC Therapeutics Inc. 24
Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Not applicableStudy completedNCT03222258
What this trial is testing

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Who this might be right for
Stage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more
Seoul National University Hospital 444
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Study completedNCT03554473
What this trial is testing

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Who this might be right for
Carcinoma, Small CellLung CancerSmall Cell Lung Cancer
National Cancer Institute (NCI) 37
Next Page